Rhu-pGSN

recombinant human plasma gelsolin · BioAegis Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Rhu-pGSN, covering 2023-02-09 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) [Phase 2]